Candidate gene studies of a promising intermediate phenotype: Failure to replicate

Neuropsychopharmacology

Volumn 38, Issue 5, 2013, Pages 802-816

  Hart, Amy B ^a   De Wit, Harriet ^a   Palmer, Abraham A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

candidate gene; D amphetamine; genetic association; intermediate phenotype; replication

Indexed keywords

AMPHETAMINE; DNA; PLACEBO;

ADULT; ALLELE; ARTICLE; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; NORMAL HUMAN; PHARMACOGENETICS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY CONTROL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; CLINICAL TRIALS AS TOPIC; DOUBLE-BLIND METHOD; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MINISATELLITE REPEATS; MOOD DISORDERS; PHENOTYPE; PROBABILITY; QUESTIONNAIRES; RISK FACTORS; YOUNG ADULT;

EID: 84875216334     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.245     Document Type: Article

References (60)

1. Alexander RC, Wright R, Freed W (1996). Quantitative trait loci contributing to phencyclidine-induced and amphetamine-induced locomotor behavior in inbred mice. Neuropsychopharmacology 15: 484-490.
2. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. Editorial Policy on Association Studies http://onlinelibrary. wiley.com/journal/10.1002/(ISSN)1552-485X/homepage/ForAuthors.html.
3. Anonymous (2005). Framework for a fully powered risk engine. Nat Genet 37: 1153.
4. Barsh GS, Copenhaver GP, Gibson G, Williams SM (2012). Guidelines for genome-wide association studies. Plos Genet 8: e1002812.
5. Bennett C, Baird AA, Miller MB, Wolford GL (2011). Neural correlates of interspecies perspective taking in the post-Mortem Atlantic Salmon: an argument for proper multiple comparisons correction. J Serendipitous Unexpected Results 1: 1-5.
6. Benowitz NL, Pomerleau OF, Pomerleau CS, Jacob P (2003). Nicotine metabolite ratio as a predictor of cigarette consumption. Nicotine Tob Res 5: 621-624.
7. Bosker FJ, Hartman CA, Nolte IM, Prins BP, Terpstra P, Posthuma D et al (2011). Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol Psychiatry 16: 516-532.
8. Chait L, Fischman MW, Schuster CR (1985). 'Hangover' effects the morning after marijuana smoking. Drug Alcohol Depend 15: 229-238.
9. Crabbe J, Jarvik L, Liston E, Jenden D (1983). Behavioral responses to amphetamines in identical twins. Acta Genet Med Gemellol (Roma) 32: 139-149.
10. Daly AK (2010). Genome-wide association studies in pharmacogenomics. Nat Rev Genet 11: 241-246.
11. Dlugos A, Freitag C, Hohoff C, McDonald J, Cook E, Deckert J et al (2007). Norepinephrine transporter gene variation modulates acute response to D-amphetamine. Biol Psychiatry 61: 1296-1305.
12. Dlugos AM, Hamidovic A, Hodgkinson C, Shen PH, Goldman D, Palmer AA et al (2011). OPRM1 gene variants modulate amphetamine-induced euphoria in humans. Genes Brain Behav 10: 199-209.
13. Dlugos AM, Hamidovic A, Hodgkinson CA, Goldman D, Palmer AA, de Wit H (2010). More aroused, less fatigued: fatty acid amide hydrolase gene polymorphisms influence acute response to amphetamine. Neuropsychopharmacology 35: 613-622.
14. Dlugos AM, Hamidovic A, Palmer AA, Wit H (2009). Further evidence of association between amphetamine response and SLC6A2 gene variants. Psychopharmacology (Berl) 206: 501-511.
15. Durbin R, Abecasis G, Altshuler D, Auton A, Brooks L, Gibbs R et al (2010). A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073.
16. Fehrmann RSN, Jansen RC, Veldink JH, Westra H-J, Arends D, Bonder MJ et al (2011). Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. Plos Genet 7: e1002197.
17. Flanagin B, Cook Jr E, de Wit H (2006). An association study of the brain-derived neurotrophic factor Val66Met polymorphism and amphetamine response. Am J Med Genet B 141: 576-583.
18. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA et al (2007). A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851-861.
19. Furberg H, Kim Y, Dackor J, Boerwinkle E, Franceschini N, Ardissino D et al (2010). Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet 42: 441-447.
20. Gamazon ER, Badner JA, Cheng L, Zhang C, Zhang D, Cox NJ et al (2012). Enrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar disorder susceptibility variants. Mol Psychiatryhttp://www.blackwellpublishing. com/pdf/G2B-Association-Studies.pdf.
21. Goldman D, Ducci F (2007). Deconstruction of vulnerability to complex diseases: enhanced effect sizes and power of intermediate phenotypes. ScientificWorldJournal 7: 124-130.
22. Gottesman II, Gould TD (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160: 636-645.
23. Grisel JE, Belknap JK, O'Toole LA, Helms ML, Wenger CD, Crabbe JC (1997). Quantitative trait loci affecting methamphetamine responses in BXD recombinant inbred mouse strains. J Neurosci 17: 745-754.
24. Hamidovic A, Dlugos A, Palmer A, de Wit H (2010a). Catechol- Omethyltransferase val158met genotype modulates sustained attention in both the drug-free state and in response to amphetamine. Psychiatr Genet 20: 85.
25. Hamidovic A, Dlugos A, Palmer AA, de Wit H (2010b). Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of d-amphetamine: an exploratory pharmacogenetic study using healthy volunteers. Behav Genet 40: 255-261.
26. Hamidovic A, Dlugos A, Skol A, Palmer AA, de Wit H (2009). Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants. Exp Clin Psychopharmacol 17: 374-383.
27. Hart AB, Engelhardt BE, Wardle MC, Sokoloff G, Stephens M, de Wit H et al (2012). Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13). PLoS ONE 7: e42646.
28. Hewitt JK (2012). Editorial policy on candidate gene association and candidate gene-by-environment interaction studies of complex traits. Behav Genet 42: 1-2.
29. Ho MK, Goldman D, Heinz A, Kaprio J, Kreek MJ, Li MD et al (2010). Breaking barriers in the genomics and pharmacogenetics of drug addiction. Clin Pharmacol Ther 88: 779-791.
30. Hodgkinson CA, Enoch M-A, Srivastava V, Cummins-Oman JS, Ferrier C, Iarikova P et al (2010). Genome-wide association identifies candidate genes that influence the human electroencephalogram. Proc Natl Acad Sci USA 107: 8695-8700.
31. Hodgkinson CA, Yuan Q, Xu K, Shen P-H, Heinz E, Lobos EA et al (2008). Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol 43: 505-515.
32. Hohoff C, Mcdonald JM, Baune BT, Cook EH, Deckert J, de Wit H (2005). Interindividual variation in anxiety response to amphetamine: possible role for adenosine A 2Areceptor gene variants. Am J Med Genet 139B: 42-44.
33. Howie BN, Donnelly P, Marchini J (2009). A flexible and accurate genotype imputation method for the next generation of genomewide association studies. Plos Genet 5: e1000529.
34. Johanson C, Uhlenhuth E (1980). Drug preference and mood in humans: diazepam. Psychopharmacology (Berl) 71: 269-273.
35. Joober R, Grizenko N, Sengupta S, Amor LB, Schmitz N, Schwartz G et al (2007). Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate. Neuropsychopharmacology 32: 1370-1376.
36. Kamens HM, Burkhart-Kasch S, McKinnon CS, Li N, Reed C, Phillips TJ (2005). Sensitivity to psychostimulants in mice bred for high and low stimulation to methamphetamine. Genes Brain Behav 4: 110-125.
37. Lerman C, Tyndale R, Patterson F, Wileyto EP, Shields PG, Pinto A et al (2006). Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clin Pharmacol Ther 79: 600-608.
38. Logan G, Cowan W, Davis K (1984). On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol 10: 276-291.
39. Lott D, Kim S, Cook E, de Wit H (2005). Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology 30: 602-609.
40. Lott D, Kim S, Cook E Jr, de Wit H (2006). Serotonin transporter genotype and acute subjective response to amphetamine. Amer J Addiction 15: 327-335.
41. Macgregor S, Lind PA, Bucholz KK, Hansell NK, Madden PAF, Richter MM et al (2009). Associations of ADH and ALDH2 gene variation with self report alcohol reactions, consumption and dependence: an integrated analysis. Hum Mol Genet 18: 580-593.
42. Martin W, Sloan J, Sapira J, Jasinski D (1971). Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12: 245-258.
43. Mathieson I, Munafò MR, Flint J (2012). Meta-analysis indicates that common variants at the DISC1 locus are not associated with schizophrenia. Mol Psychiatry 17: 634-641.
44. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JPA et al (2008). Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9: 356-369.
45. Munafò MR, Brown SM, Hariri AR (2008). Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiatry 63: 852-857.
46. Munafò MR, Matheson IJ, Flint J (2007). Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias. Mol Psychiatry 12: 454-461.
47. Murphy SE, Norbury R, Godlewska BR, Cowen PJ, Mannie ZM, Harmer CJ et al (2012). The effect of the serotonin transporter polymorphism (5-HTTLPR) on amygdala function: a metaanalysis. Mol Psychiatry (e-pub ahead of print).
48. Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, Cox NJ (2010). Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. Plos Genet 6: e1000888.
49. Nurnberger J, Gershon ES, Simmons S, Ebert M, Kessler L, Dibble E et al (1982). Behavioral, biochemical and neuroendocrine responses to amphetamine in normal twins and 'well-state' bipolar patients. Psychoneuroendocrinology 7: 163-176.
50. Patterson N, Price AL, Reich D (2006). Population structure and eigenanalysis. Plos Genet 2: e190.
51. Poldrack RA, Mumford JA (2009). Independence in ROI analysis: where is the voodoo? Soc Cogn Affect Neurosci 4: 208-213.
52. Ripke S, Sanders AR, Kendler KS, Levinson DF, Sklar P, Holmans PA et al (2011). Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43: 969-976.
53. Schadt EE, Molony C, Chudin E, Hao K, Yang X, Lum PY et al (2008). Mapping the genetic architecture of gene expression in human liver. PLoS Biol 6: e107.
54. Stein MA, Waldman ID, Sarampote CS, Seymour KE, Robb AS, Conlon C et al (2005). Dopamine transporter genotype and methylphenidate dose response in children with ADHD. Neuropsychopharmacology 1-9.
55. Sullivan PF (2007). Spurious genetic associations. Biol Psychiatry 61: 1121-1126.
56. Veenstra-VanderWeele J, Qaadir A, Palmer AA, Cook EH, de Wit H (2006). Association between the Casein Kinase 1 Epsilon gene region and subjective response to D-amphetamine. Neuropsychopharmacology 31: 1056-1063.
57. Wall TL, Shea SH, Luczak SE, Cook TAR, Carr LG (2005). Genetic associations of alcohol dehydrogenase with alcohol use disorders and endophenotypes in white college students. J Abnorm Psychol 114: 456-465.
58. Wechsler D (1958). The measurement and appraisal of adult intelligence. J Med Educ 33: 706.
59. White TL, Justice AJH, de Wit H (2002). Differential subjective effects of d-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacology, Biochemistry and Behavior 73: 729-741.
60. Zombeck JA, Swearingen SP, Rhodes JS (2010). Acute locomotor responses to cocaine in adolescents vs adults from four divergent inbred mouse strains. Genes Brain Behav 9: 892-898.